(PharmaNewsWire.Com, January 21, 2019 ) The Insight Partners published an Exclusive report on “Multiplex Assays Market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 150 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
The increase in adoption of multiplex assay in diagnostics, launch of technologically advanced products, increasing R&D activities in life science research, growing biotechnology sector and increase in investments by biopharmaceutical companies are likely aid in the growth for global multiplex assays market. Also the technological advancements in nanotechnology has led to the development of nanoarray technique which is expected to add novel opportunities in the forecast period for global multiplex assays market.
Some of the key players are Thermo Fisher Scientific Inc, Illumina Inc, Bio-Rad Laboratories Inc, Qiagen, Abcam plc, BD, Agilent Technologies, Quanterix, Bio-Techne, Seegene Inc. among others. Global Multiplex Assays Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade journals, technical white papers, paid databases etc. followed by primary research (interviews) with industry experts/KOLs to gain their insights and views on current scenarios and future scope of the market as well as validating the secondary information, further internal statistical model is used to estimate the market size and forecasts till 2027.
Multiplex assays are type of immunoassay where multiple analytes are measured in a single experimental run. Multiplex assays are derived from ELISA technique where beads are used for binding the antibody. These assays are used more for research purposes than for clinical applications. The potential advantages of these assays like its ability to independently and quantitatively measure multiple analytes at the same time in small volumes of biologic sample, also these assays offer cost effective and time saving quantification. Thus, provides a strong impetus for the routine use of these in both the research and clinical laboratories.
Multiplex Assays Market – Global Analysis to 2027 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/position of top 5 key vendors.
Table of Content: Chapter 1. Methodology Chapter 2. Executive Summary Chapter 3. Multiplex Assays Industry Insights Chapter 4. Multiplex Assays Market, By Technology Chapter 5. Multiplex Assays Market, By End-user Chapter 6. Multiplex Assays Market, By Region Chapter 7. Company Profiles
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
